Novel Technology for Intervening in Non-Compressible Haemorrhage

Overview

DASA are seeking proposals for novel innovations that intervene to stop non-compressible bleeding.

This competition is being run on behalf of Defence Medical Services (DMS) and UK Research & Innovation (UKRI).

This competition is seeking novel interventions starting at Technology Readiness Level (TRL) 2-4, for NCH for use prehospital in both combat and civilian settings.

Scope

Non-compressible haemorrhage (NCH) refers to significant bleeding that cannot be immediately stopped or sustainably controlled from application of external pressure. NCH remains the leading cause of potentially preventable death in conflict. Despite significant improvements in combat casualty care, and reductions in overall mortality, patients with significant NCH face a high chance of dying from their injuries before they can reach a surgical facility.

DASA are seeking proposals for novel innovations that intervene to stop non-compressible bleeding. In this case ‘novel’ refers to products currently between TRL 2-4. Products can start anywhere in the TRL 2-4 range and can progress as far as feasible within the timeframe of the project. We expect funded products to progress by one or more TRLs by project end.

DASA are looking for engineering technology-driven, design-led solutions aimed at device-enabled control of haemorrhage. DASA encourage solutions that exploit and integrate existing technologies or approaches used or developed in non-healthcare sectors that could be re-oriented for the NCH challenge.